MENU
DRUG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Bright Minds Biosciences (DRUG) Ownership - Who owns Bright Minds Biosciences?
Profile
Industry
N/A
Address
19 Vestry Street
Phone
+1 647 865-8622
Employees
N/A
Web
https://www.brightmindsbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
275.39M
P/E Ratio
N/A
Total Cash
6.19M
Projected Growth
N/A
Total Debt
14.02K
Revenue
N/A
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash/Share
0.89
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DRUG
Capitalization
275M
P/E Ratio
N/A
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash
6.19M
Total Cash/Share
0.89
Total Debt
14K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
6.1M
P/B Ratio
63.29
Cash Flow
N/A
Earnings
-0.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
35M
Current Ratio
35.08
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-3.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.26
Shares Held By Institutions
203K
Shares Outstanding - Current
6.97M
Total Liabilities
179K
Total Volume MTD
N/A
Value
-1
Gain YTD
2679.720
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
19 Vestry Street
Phone
+1 647 865-8622
Employees
N/A
Web
https://www.brightmindsbio.com